Biognosys Immunopeptidome Profiling Solution for MHC Class I And Class II Neoantigens Discovery in Tumor Biopsies – Case Study

The case study elaborates on the latest study on lung cancer we performed with our high-throughput TrueDiscovery™ platform for immunopeptidome profiling from needle-sized biopsies. We identified > 11,000 Class I and > 9,000 Class II immunopeptides on average.